2021 | Health Technology Assessment Division

Evidence brief for 25 September to 01 October 2021

Posted on October 4, 2021

For the period of 25 September to 01 October 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 25 September to 01 October 2021

[Department Circular No. 2021- 0423] Inclusion of Dolutegravir (DTG) in the Philippine National Formulary (PNF)

Posted on September 28, 2021

Evidence brief for 18 September to 24 September 2021

Posted on September 27, 2021

For the period of 18 September to 24 September 2021 Reviewed by: Department of Health (DOH) – Health Technology Assessment Unit (HTAU) Document Link: 18 September to 24 September

[Signed by Secretary of Health] Letter of Endorsement for Dolutegravir for the Second-line Treatment for Treatment Experienced Adolescents and Adults Living with HIV

Posted on September 21, 2021

[Department Circular No. 2021- 0410] Inclusion of Two-Dose Inactivated Polio Vaccine (IPV) in the Philippine National Formulary (PNF)

Posted on September 20, 2021